Reports/SNPS
SNPS

SNPS - Synopsys Inc

OPPORTUNISTIC BUYAWAIT ENTRY2026-08-11Data 12 days oldUSD 411.68
50
Conviction
out of 100

Executive Summary

Synopsys Inc (SNPS) is a supplier of electronic design automation (EDA) software, semiconductor intellectual property (IP), and software integrity solutions used by chip designers, system-on-chip developers, and enterprise software teams to design, verify, and test advanced semiconductors and electronic systems. The company holds a market-leading position in the EDA software segment alongside Cadence Design Systems, with deep entrenchment across the global semiconductor and systems design chain.

The investment case rests on Synopsys continuing to convert rising AI-related chip design demand into above-trend revenue and earnings growth, with the Q3 FY2026 release on 26 August 2026 as the next decisive near-term event. The primary risk is that the shares already price in much of that AI-led acceleration, leaving limited margin for any disappointment against an elevated earnings multiple.

OPPORTUNISTIC BUY. Conviction Score: 50/100. The view would shift higher on a clean Q3 FY2026 beat-and-raise with continued AI revenue traction, and lower on any sign of design-tool demand cooling or margin compression at the next print.

Wait for entry. Current price USD 411.68 is 7.4% above the buy ceiling of USD 383.33. New positions only below the ceiling.
AWAIT ENTRYOPPORTUNISTIC BUY · 50/100Now USD 411.68 · buy ≤ USD 383.33 · trim ≥ USD 470.00

Thesis break: The thesis is invalidated by a Q3 FY2026 print below the 3.630 EPS guidance floor combined with downward full-year guidance, or by evidence of a sustained deceleration in AI-related EDA and IP revenue growth below the level required to justify the current valuation.

Business Model

Synopsys generates revenue predominantly through time-based and subscription licences for its EDA software tools, supplemented by upfront and royalty streams from its semiconductor IP portfolio (including interface, processor, and analogue IP blocks licensed to chip makers). A smaller but strategically important software integrity segment supplies static application security testing, software composition analysis, and related security tools to enterprise software developers under subscription. Customers are largely global semiconductor companies, fabless chip designers, integrated device manufacturers, hyperscale technology firms building custom silicon, and large enterprises with in-house software development teams.

The competitive moat is built on the mission-critical nature of chip design flows, multi-year customer integration, and the substantial switching cost of retraining engineering teams on rival EDA platforms. Synopsys and Cadence have historically divided the majority of advanced-node design engagements, while Siemens EDA competes in adjacent segments, leaving the top tier of advanced semiconductor design effectively a three-vendor market. Recurring software revenue provides visibility, with the IP and software integrity lines layering additional growth optionality, particularly as AI accelerator and high-performance compute designs drive demand for Synopsys's IP and verification toolchains.

Reported metrics indicate the operating model is high-quality from a margin standpoint but currently premium-priced on a relative basis, with the trailing P/E around 95x requiring sustained AI-driven revenue acceleration to be justified. Q2 FY2026 results referenced in the research data showed revenue growth of approximately 42% year on year, signalling that demand for AI chip design tools and IP is currently a meaningful tailwind for the top line.

Financial Snapshot

Price
USD 411.68
Market Cap
USD 78.8bn
P/E Ratio
95.4x
52w High
USD 628.89
52w Low
USD 366.00
Distance from 52wH
-34.5%
Beta
1.23
Avg Volume
1982276
Currency
USD

Recent Catalysts

[22 July 2026] - Synopsys announced it will report its third quarter fiscal 2026 results on Wednesday, 26 August 2026, after market close, confirming the next scheduled earnings event for the company. Source: Synopsys, Inc. press release via Stock Titan.

[22 July 2026] - Synopsys disclosed Q3 FY2026 EPS guidance of 3.630 to 3.690 for the period, framing the consensus bar ahead of the late-August print. Source: Ticker Report (sourced from company guidance release).

[Q2 FY2026 (reported prior to August 2026)] - Synopsys reported Q2 FY2026 revenue growth of approximately 42% year on year, with the research data also flagging a prior earnings beat, a guidance raise, and an Elliott partnership as already-digested Q2 catalysts. Source: Yahoo Finance summary of company-reported Q2 FY2026 results.

[26 August 2026, upcoming] - Synopsys is scheduled to report Q3 FY2026 results after market close, with management commentary on AI design demand, IP trends, and software integrity expected to set the near-term tone. Source: Synopsys Investor Relations earnings date announcement.

Thesis Evaluation

Bull Case (15% weight)

AI-driven chip design demand sustains the Q2 FY2026 trajectory, Q3 FY2026 prints ahead of the 3.630 to 3.690 EPS guidance range, and full-year guidance is raised again, with the Elliott partnership translating into accretive capital allocation. A re-rating towards a still-rich but defensible multiple on demonstrated AI-led growth supports a 12-month price target of $560.

Base Case (50% weight)

Synopsys delivers Q3 FY2026 broadly in line with disclosed EPS guidance of 3.630 to 3.690, AI-related revenue continues to grow at a healthy double-digit pace, and the operating margin profile holds steady without further multiple expansion. The shares drift higher as fundamentals compound but the premium P/E caps upside, supporting a 12-month price target of $470.

Bear Case (35% weight)

AI design demand cools, Q3 FY2026 disappoints versus the 3.630 to 3.690 EPS guidance band, or margin guidance is held flat, exposing the ~95x trailing P/E as unsustainable. Multiple compression drives a 12-month downside to $340.

Weighted conviction:Bull (15%) x 100 + Base (50%) x 62 + Bear (35%) x 10 = 50/100. OPPORTUNISTIC BUY.

Key Risks

  1. Valuation risk on an elevated P/E: With a trailing P/E around 95x, the shares leave limited room for any earnings or guidance disappointment, with even a modest miss likely to trigger sharp multiple compression. Estimated probability: 45%. Impact: severe.
  2. AI demand cyclicality: A slowdown in AI accelerator and high-performance compute design activity would directly reduce demand for Synopsys's EDA tools and semiconductor IP, undermining the growth narrative underpinning the current multiple. Estimated probability: 30%. Impact: severe.
  3. Competitive pressure in EDA and IP: Sustained competition from Cadence and Siemens EDA, or new entrants in AI-specific design tooling, could pressure licence pricing and IP royalty growth over time. Estimated probability: 25%. Impact: moderate.
  4. Geopolitical and export control exposure: US export restrictions on advanced semiconductor design tools and IP to China could constrain addressable revenue and create recurring headline risk around the China customer base. Estimated probability: 35%. Impact: moderate.
  5. Activist-influenced capital allocation missteps: While the Elliott partnership is currently framed as constructive, activist involvement raises the possibility of value-destructive moves if capital return or portfolio actions are poorly timed relative to the AI demand cycle. Estimated probability: 15%. Impact: moderate.

Who Should Own It / Avoid It

Ideal for: long-duration growth and technology investors with a minimum 18 to 24 month holding horizon, a high tolerance for earnings multiple volatility, and a portfolio already exposed to the semiconductor design and AI infrastructure theme who want pure-play EDA and semiconductor IP exposure. The position size should reflect that conviction is deliberately measured at 50/100 rather than high.

Avoid if: investors require a margin of safety underpinned by a low trailing P/E, have a short-term trading horizon through the 26 August 2026 earnings event, are unable to tolerate a meaningful drawdown if the AI-led growth narrative stalls, or require dividend income, as Synopsys's cash return profile is not the primary attraction here.

Recommendation

OPPORTUNISTIC BUY - 50/100. The OPPORTUNISTIC BUY tier reflects a constructive but not high-conviction stance: the AI design thesis and Q2 FY2026 execution are real positives, but the ~95x trailing P/E demands continued perfection and leaves the position vulnerable to any Q3 FY2026 misstep. The call would be upgraded towards a higher tier on a clean Q3 FY2026 beat-and-raise with sustained AI revenue traction and clearer evidence of margin durability. Conversely, the call would be downgraded on any Q3 FY2026 miss versus the 3.630 to 3.690 EPS guidance range, soft forward commentary on AI design demand, or evidence of incremental competitive or geopolitical pressure on the EDA and IP franchises. At the current price of $411.68 the shares trade above our buy ceiling of $383.33: the thesis is credible but the price is not - new positions only below that level.

The probability-weighted value across our three scenarios is $438.00, 6% above the current price of $411.68 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.

BUY

below $383.33 - below this level the upside to the base-case target ($470.00) is at least 2x the downside to the bear case ($340.00), the minimum risk/reward we require before committing new capital.

HOLD

between $383.33 and $470.00 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.

REDUCE

above $470.00 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 15%.

SELL

if the thesis is invalidated by a Q3 FY2026 print below the 3.630 EPS guidance floor combined with downward full-year guidance, or by evidence of a sustained deceleration in AI-related EDA and IP revenue growth below the level required to justify the current valuation, regardless of price - the bear target of $340.00 is the backstop, not an arbitrary percentage stop.

Conviction Trend

Latest conviction: 50/100. Trend versus prior report: Initiation.

CONVBUYOPPSPECAVOID1007550250Conviction (0-100)2026-08-11
CONVICTION BUY (80+)BUY (65 - 79)OPP BUY (50 - 64)SPEC BUY (30 - 49)AVOID (0 - 29)
Report dateConviction
2026-08-1150

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: Public news flow draws on company press releases, the Synopsys Investor Relations earnings date announcement, earnings-related reporting from financial news wires, and aggregators carrying the issuer's Q3 FY2026 EPS guidance and earnings calendar entries. No proprietary sentiment or scoring tool is cited; sentiment is inferred solely from public reporting.

Primary source types: SEC filings, Synopsys press releases, the Synopsys Investor Relations quarterly results and news pages, regulatory and exchange announcements, and third-party research summarising company-reported quarterly results and guidance.

Key sources

Data correct as of 2026-08-11